Etoposide Injection 100 mg/5 mL (1) Australie - anglais - Department of Health (Therapeutic Goods Administration)

etoposide injection 100 mg/5 ml (1)

pfizer (perth) pty ltd - etoposide, quantity: 20 mg/ml - injection, intravenous infusion - excipient ingredients: macrogol 300; citric acid; polysorbate 80; ethanol absolute - - small cell carcinoma of the lung. - acute monocytic and myelomonocytic leukaemia. - hodgkin's disease - non-hodgkin's lymphoma.

Etoposide 100 mg/5 mL Injection (Bulk) Australie - anglais - Department of Health (Therapeutic Goods Administration)

etoposide 100 mg/5 ml injection (bulk)

pfizer (perth) pty ltd - etoposide, quantity: 20 mg/ml - injection, intravenous infusion - excipient ingredients: macrogol 300; citric acid; polysorbate 80; ethanol absolute - for the treatment of small cell lung cancer and testicular tumours, either as a single agent or in combination with other anticancer agents.

Etoposide (Pfizer) Nouvelle-Zélande - anglais - Medsafe (Medicines Safety Authority)

etoposide (pfizer)

pharmacia limited company trading as pharmacia - etoposide 20mg - solution for injection - 20 mg/ml - active: etoposide 20mg excipient: citric acid ethanol macrogol 300 polysorbate 80

Etoposide (Pacific) Nouvelle-Zélande - anglais - Medsafe (Medicines Safety Authority)

etoposide (pacific)

viatris limited - etoposide 20 mg/ml - solution for infusion - 100 mg/5ml - active: etoposide 20 mg/ml excipient: benzyl alcohol citric acid ethanol macrogol 300 nitrogen polysorbate 80

ETOPOSIDE - HEXAL 50 mg/2,5 ml INFUSION (PARENTERAL) Afrique du Sud - anglais - South African Health Products Regulatory Authority (SAHPRA)

etoposide - hexal 50 mg/2,5 ml infusion (parenteral)

sandoz south africa (pty) ltd - infusion (parenteral) - see ingredients - each 2,5 ml solution contains etoposide 50,0 mg

ETOPOSIDE - HEXAL 100 mg/5 ml INFUSION (PARENTERAL) Afrique du Sud - anglais - South African Health Products Regulatory Authority (SAHPRA)

etoposide - hexal 100 mg/5 ml infusion (parenteral)

sandoz south africa (pty) ltd - infusion (parenteral) - see ingredients - each 5,0 ml solution contains etoposide 100,0 mg

ETOPOSIDE-HEXAL 200 mg/10ml INFUSION (PARENTERAL) Afrique du Sud - anglais - South African Health Products Regulatory Authority (SAHPRA)

etoposide-hexal 200 mg/10ml infusion (parenteral)

sandoz south africa (pty) ltd - infusion (parenteral) - 200 mg - each 10 ml solution contains etoposide

ETOPOSIDE-HEXAL 400 mg/20ml INFUSION (PARENTERAL) Afrique du Sud - anglais - South African Health Products Regulatory Authority (SAHPRA)

etoposide-hexal 400 mg/20ml infusion (parenteral)

sandoz south africa (pty) ltd - infusion (parenteral) - 400 mg - each 20 ml solution contains etoposide

ETOPOSIDE - HEXAL 1 000 mg /50 ml Infusion Afrique du Sud - anglais - South African Health Products Regulatory Authority (SAHPRA)

etoposide - hexal 1 000 mg /50 ml infusion

sandoz south africa (pty) ltd - infusion - each 50,0 ml solution contains etoposide 1 000,0 mg

Etoposide-Hexal 100mg/5ml Namibie - anglais - Namibia Medicines Regulatory Council

etoposide-hexal 100mg/5ml

sandoz sa (pty) ltd - etoposide - solution for infusion - each 5ml solution contains etoposide 100.0 mg